🇺🇸 FDA
Patent

US 11319302

PRC1 inhibitors and methods of treatment therewith

granted A61KA61K31/404A61K31/4184

Quick answer

US patent 11319302 (PRC1 inhibitors and methods of treatment therewith) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Apr 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue May 03 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/404, A61K31/4184, A61K31/422, A61K31/427